2018 annual financial data
Monopar Therapeutics 2018 Net income growth
Direct answer
Net income growth was 80.5%.
Operating income was -3,402,762 USD and net income was -3,227,932 USD.
Operating cash flow was -2,886,757 USD.
Get free Monopar Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -3,402,762 USD
- Net income
- -3,227,932 USD
- Operating cash flow
- -2,886,757 USD